Skip to Content

WPI 2234 (Tetracycline 250 mg)

Pill imprint WPI 2234 has been identified as Tetracycline hydrochloride 250 mg.

Tetracycline is used in the treatment of acne; upper respiratory tract infection; bladder infection; syphilis, early; epididymitis, sexually transmitted (and more), and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Tetracycline 250 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.